Anteris announces presentation of one-year DurAVR outcomes in 100 patients at PCR Valves conference
AVR•Anteris Technologies will participate in PCR London Valves, Nov. 22-24, 2026. Cleveland Clinic’s Rishi Puri will present one-year clinical and hemodynamic outcomes for 100 patients with severe aortic stenosis who received the DurAVR transcatheter heart valve.
1. Conference presentation
Anteris Technologies will participate in PCR London Valves in London from Nov. 22-24, 2026. Cleveland Clinic’s Rishi Puri will present one-year DurAVR outcomes in a late-breaking session on Nov. 22, covering clinical and hemodynamic outcomes in 100 patients with severe aortic stenosis who received the valve.




